Exchange: NASDAQ·Updated 04:04 PM EST
BHST logo

BHST BioHarvest Sciences Inc

$1.31
$0.02
(1.51%)
Today
Closed $1.30
$0.01
(0.77%)
After Hours
Reported EarningsNov 12
Mkt Cap$29.47M
Vol9,718.00

About BHST

BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The firm engages in botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions. It offers nutraceutical health and wellness products, which includes dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients. The company was founded on April 19, 2013 and is headquartered in Vancouver, Canada.
41

Bearish Sentiment

How do you feel about BHST?

StocktwitsEarnings
$BHST Q3 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.15 down -7.14% YoY • Reported revenue of $7.87M down -13.23% YoY • BioHarvest revised full-year 2026 consolidated revenue guidance to $3.23B and expects Adjusted EBITDA loss of $5.58M; VINIA D2C revenue guidance is $3.13B and CDMO revenue guidance is $11.5M.

Advertisement|Remove ads.